SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Chemed Corp. – ‘8-K’ for 4/17/24

On:  Wednesday, 4/17/24, at 10:15am ET   ·   For:  4/17/24   ·   Accession #:  1562762-24-90   ·   File #:  1-08351

Previous ‘8-K’:  ‘8-K’ on / for 3/13/24   ·   Next & Latest:  ‘8-K’ on / for 4/24/24

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 4/17/24  Chemed Corp.                      8-K:2       4/17/24   11:208K                                   Certent, Inc./FA

Current Report   —   Form 8-K

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report                                      HTML     67K 
 2: EX-99.1     Miscellaneous Exhibit                               HTML     11K 
 6: R1          Document And Entity Information                     HTML     47K 
 8: XML         IDEA XML File -- Filing Summary                      XML     11K 
11: XML         XBRL Instance -- che-20240417x8k_htm                 XML     16K 
 7: EXCEL       IDEA Workbook of Financial Report Info              XLSX      8K 
 4: EX-101.LAB  XBRL Labels -- che-20240417_lab                      XML     58K 
 5: EX-101.PRE  XBRL Presentations -- che-20240417_pre               XML     33K 
 3: EX-101.SCH  XBRL Schema -- che-20240417                          XSD     11K 
 9: JSON        XBRL Instance as JSON Data -- MetaLinks               12±    18K 
10: ZIP         XBRL Zipped Folder -- 0001562762-24-000090-xbrl      Zip     15K 


‘8-K’   —   Current Report


This is an HTML Document rendered as filed.  [ Alternative Formats ]



 iX:   C: 
  che-20240417x8k  
 i false i 000001958400000195842024-04-172024-04-17

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C.  20549

FORM  i 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (date of earliest event reported):

 i April 17, 2024

 i CHEMED CORPORATION

(Exact name of registrant as specified in its charter)

 i Delaware

      i 1-8351

   i 31-0791746

(State or other
jurisdiction of
incorporation)

(Commission File Number)

(I.R.S. Employer
Identification
Number)

 i 2600 First Financial Center,  i 255 East 5th Street,  i Cincinnati,  i OH  i 45202

(Address of principal executive offices)             (Zip Code)

Registrant's telephone number, including area code:

( i 513)  i 762-6690

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2 below):

 i [_]      Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 i [_]      Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240-14a-12)

 i [_]      Pre-commencement communications pursuant to Rule 14d-2(b) under Exchange Act (17 CFR 240-14d-2(b))

 i [_]      Pre-commencement communications pursuant to Rule 13e-4 (c) under Exchange Act (17 CFR 240-13e-4(c))

Securities registered pursuant to 12(b) of the Act:

 

Title of each class

 

Trading symbol

Name of each exchange on which

registered

 i Capital stock $1 par value

 i CHE

 i NYSE

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934.   i [_]

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  [_]

Page 1 of 4


Item 2.01 Completion of Acquisition or Disposition of Assets

VITAS Acquisition

On April 17, 2024, Chemed issued a press release announcing that VITAS Healthcare Corporation (“VITAS”), a wholly-owned indirect subsidiary of Chemed, completed its acquisition of substantially all hospice operations and an assisted living facility from Covenant Health and Community Services, Inc., d/b/a Covenant Care, a Florida not for profit corporation (“Covenant”), for $85 million. Covenant operated hospice services in the panhandle of Florida and Alabama, including the Pensacola, Tallahassee, Marianna, Fort Walton Beach, Crestview and Panama City markets in Florida, and Dothan and Mobile market in Alabama. The purchase was made using cash on-hand.

A copy of the press release announcing the events described above is attached hereto as Exhibit 99.1.

Page 2 of 4


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

CHEMED CORPORATION

Dated:   April 17, 2024

By:

/s/ Michael D. Witzeman

Michael D. Witzeman

Chief Financial Officer, Vice President and Controller

Page 3 of 4


Exhibit Index

Exhibit No.  Description

99.1   Press Release dated April 17, 2024

104   The cover page from this Current Report on Form 8-K formatted in Incline XBRL

Page 4 of 4


Dates Referenced Herein

This ‘8-K’ Filing    Date    Other Filings
Filed on / For Period end:4/17/24None on these Dates
 List all Filings 
Top
Filing Submission 0001562762-24-000090   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Tue., Apr. 30, 1:15:28.2pm ET